X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE DISHMAN PHARMA SUVEN LIFE/
DISHMAN PHARMA
 
P/E (TTM) x 21.2 25.1 84.5% View Chart
P/BV x 4.6 3.3 138.4% View Chart
Dividend Yield % 0.5 0.7 74.2%  

Financials

 SUVEN LIFE   DISHMAN PHARMA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
DISHMAN PHARMA
Mar-16
SUVEN LIFE/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs251374 67.0%   
Low Rs155129 120.2%   
Sales per share (Unadj.) Rs49.1197.8 24.8%  
Earnings per share (Unadj.) Rs9.721.2 45.8%  
Cash flow per share (Unadj.) Rs11.434.7 32.8%  
Dividends per share (Unadj.) Rs1.502.00 75.0%  
Dividend yield (eoy) %0.70.8 93.0%  
Book value per share (Unadj.) Rs60.3179.9 33.5%  
Shares outstanding (eoy) m127.2880.69 157.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.11.3 324.6%   
Avg P/E ratio x20.911.9 175.9%  
P/CF ratio (eoy) x17.87.2 245.8%  
Price / Book Value ratio x3.41.4 240.6%  
Dividend payout %15.49.4 163.7%   
Avg Mkt Cap Rs m25,82520,306 127.2%   
No. of employees `0001.10.8 129.3%   
Total wages/salary Rs m6135,355 11.4%   
Avg. sales/employee Rs Th5,832.619,252.7 30.3%   
Avg. wages/employee Rs Th571.56,459.5 8.8%   
Avg. net profit/employee Rs Th1,153.82,064.1 55.9%   
INCOME DATA
Net Sales Rs m6,25315,961 39.2%  
Other income Rs m233265 87.7%   
Total revenues Rs m6,48516,226 40.0%   
Gross profit Rs m1,9824,103 48.3%  
Depreciation Rs m2131,091 19.5%   
Interest Rs m46944 4.9%   
Profit before tax Rs m1,9552,334 83.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718624 115.2%   
Profit after tax Rs m1,2371,711 72.3%  
Gross profit margin %31.725.7 123.3%  
Effective tax rate %36.726.7 137.5%   
Net profit margin %19.810.7 184.5%  
BALANCE SHEET DATA
Current assets Rs m5,62211,018 51.0%   
Current liabilities Rs m1,1689,517 12.3%   
Net working cap to sales %71.29.4 757.6%  
Current ratio x4.81.2 415.9%  
Inventory Days Days81110 73.7%  
Debtors Days Days3635 103.1%  
Net fixed assets Rs m3,32516,304 20.4%   
Share capital Rs m127161 78.9%   
"Free" reserves Rs m7,54712,907 58.5%   
Net worth Rs m7,67414,516 52.9%   
Long term debt Rs m144,189 0.3%   
Total assets Rs m9,13529,805 30.7%  
Interest coverage x43.23.5 1,245.4%   
Debt to equity ratio x00.3 0.6%  
Sales to assets ratio x0.70.5 127.8%   
Return on assets %14.08.9 157.7%  
Return on equity %16.111.8 136.7%  
Return on capital %26.017.5 148.5%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m5,0664,952 102.3%   
Fx outflow Rs m2,001697 287.2%   
Net fx Rs m3,0654,255 72.0%   
CASH FLOW
From Operations Rs m6992,786 25.1%  
From Investments Rs m-6-1,529 0.4%  
From Financial Activity Rs m-577-941 61.3%  
Net Cashflow Rs m116316 36.8%  

Share Holding

Indian Promoters % 63.4 61.4 103.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.7 -  
FIIs % 0.0 12.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 22.1 165.2%  
Shareholders   37,287 46,261 80.6%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   BIOCON LTD  CADILA HEALTHCARE  VENUS REMEDIES  PANACEA BIOTECH  WOCKHARDT LTD.  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Healthcare & Metal Stocks Gain(09:30 am)

Asian share markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1.5% while the Hang Seng is up 1.2%.

Related Views on News

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

SUVEN LIFE Announces Quarterly Results (4QFY18); Net Profit Up 56.0% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, SUVEN LIFE has posted a net profit of Rs 625 m (up 56.0% YoY). Sales on the other hand came in at Rs 2 bn (up 18.6% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

Hurricanes Threaten Oil Spike, but the Saudis are Selling...(Vivek Kaul's Diary)

Sep 6, 2018

Oil prices are rising and could go even more higher amid rising tensions in Middle East.

Should You Be Worried About the Rising Dollar?(Chart Of The Day)

Sep 7, 2018

While the rupee has deprecated by about 5% annually since 1990 against the dollar, the BSE Sensex has returned 14% annually in the same period.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Sep 19, 2018 11:13 AM

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE - DIVIS LABORATORIES COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS